Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MOMELOTINIB vs MOMETASONE FUROATE\OLOPATADINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

MOMELOTINIB vs MOMETASONE FUROATE\OLOPATADINE: Safety Overview

Metric MOMELOTINIB MOMETASONE FUROATE\OLOPATADINE
Total FAERS Reports 909 1,012
Deaths Reported 143 3
Death Rate 15.7% 0.3%
Hospitalizations 213 18
Average Patient Age 73.2 yrs 43.6 yrs
% Female Patients 49.4% 58.5%
FDA Approval Date Sep 15, 2023 N/A
Manufacturer GlaxoSmithKline LLC N/A
Route ORAL N/A
Marketing Status Prescription N/A